Login
$COO
$61.88 -$0.77 (1.23%) Live

$COO 8-K SEC Filings

Filed On Filing
27 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Independent Director and Seasoned Healthcare Executive Walt Rosebrough

09 Sep 2026 8-K: Results of Operations and Financial Condition; Other Events

San Ramon, Calif., September 9, 2026 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026.

04 Jun 2026 8-K: Results of Operations and Financial Condition; Other Events

San Ramon, Calif., June 4, 2026 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026.

04 May 2026 8-K: Departure/Election of Directors or Officers; Compensation

SAN RAMON, Calif., May 4, 2026 - CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has...

08 Apr 2026 8-K: Submission of Matters to a Vote of Security Holders

On April 7, 2026, The Cooper Companies, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders. The matters listed below were submitted to a vote of the stockholders through the solicitation of proxies, and the proposals are d...

05 Mar 2026 8-K: Results of Operations and Financial Condition

San Ramon, Calif., March 5, 2026 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2026.

04 Feb 2026 8-K: Entry into a Material Definitive Agreement

This AMENDMENT NO. 1 TO REVOLVING CREDIT AGREEMENT (this “Amendment”) is entered into as of February 3, 2026 among (i) THE COOPER COMPANIES, INC., a Delaware corporation (the “Company”) and COOPERVISION INTERNATIONAL LIMITED, a private l...

23 Dec 2025 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

This letter (this Agreement), dated and effective as of December 22, 2025, constitutes the agreement between The Cooper Companies, Inc. (the Company) and Browning West, LP (including the funds managed by it, Browning West), with respect ...

12 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation

On December 9, 2025, Brian G. Andrews, Executive Vice President, Chief Financial Officer and Treasurer of The Cooper Companies, Inc. (the “Company”), assumed the role of principal accounting officer of the Company from Agostino Ricupati,...

04 Dec 2025 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

San Ramon, Calif., December 4, 2025— CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025.

27 Aug 2025 8-K: Results of Operations and Financial Condition

San Ramon, Calif., August 27, 2025 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025.

29 May 2025 8-K: Results of Operations and Financial Condition

San Ramon, Calif., May 29, 2025 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025.

30 Apr 2025 8-K: Departure/Election of Directors or Officers; Compensation

SAN RAMON, Calif., April 30, 2025 - CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. ...

02 Apr 2025 8-K: Submission of Matters to a Vote of Security Holders

On April 2, 2025, The Cooper Companies, Inc. (the "Company") held its Annual Meeting of Stockholders. The matters listed below were submitted to a vote of the stockholders through the solicitation of proxies, and the proposals are descri...

06 Mar 2025 8-K: Results of Operations and Financial Condition

San Ramon, Calif., March 6, 2025 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2025.

05 Feb 2025 8-K: Departure/Election of Directors or Officers; Compensation

On January 31, 2025, William A. Kozy informed the Board of Directors (the "Board") that he will retire as a director, effective on the date of The Cooper Companies, Inc.'s (the "Company's") next Annual Meeting of Stockholders in April 20...

05 Dec 2024 8-K: Results of Operations and Financial Condition

San Ramon, Calif., December 5, 2024— CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024.

25 Oct 2024 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

The registered office shall be in the City of Dover, County of Kent, State of Delaware.

28 Aug 2024 8-K: Results of Operations and Financial Condition

San Ramon, Calif., August 28, 2024 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024.

30 May 2024 8-K: Results of Operations and Financial Condition

San Ramon, Calif., May 30, 2024 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2024.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support